DE EN Anmelden

In your studies 'Drug Regulator Affairs'

©Volker Lannert / Universität Bonn

Master's thesis


As part of the continuing education Master's degree programme, Master's theses are written on relevant topics in the field of 'Drug Regulatory Affairs' using scientific methods. The topics are highly topical, diverse and the results are both of interest in a scientific context and relevant to many areas of activity in 'Drug Regulatory Affairs'.

Here you will find all Master's theses written since the year 2000, including the title and a summary. In this collection, many Master's theses can also be viewed and downloaded in full text.

Further information on Master's theses (e.g. registration, processing) can be found in our ‘Master's thesis guidelines/Leitfaden für die Anfertigung einer Masterarbeit’ (in German) and in the ‘Information leaflet - Master's thesis’ at

Downloads from A-Z

Do you have any questions or are you interested in the full text of a Master's thesis that is not listed here?
Please feel free to contact me.

Dr. Jasmin Fahnenstich

Dr. Jasmin Fahnenstich

Study programme manager

Phone: +49 (0) 228 - 9268 6806

Send e-mail

Master's thesis

The collection of Master's theses can be searched and sorted by entering keywords.

Year Name Title Full text Summary
2011 Dr. Liane Söllner The need for juvenile animal studies - a critical review ***
2011 Sebastian Strobl Counterfeit drugs in industrialized and developing countries - A comparison ***
2011 Dr. Verena Tautorat The end of an era: Implementing Variation Directive 2009/53/EC into German Drug Law ***
2011 Dr. Franz Thannberger A Step beyond Module 3 of "passive" Transdermal Therapeutic Systems ***
2011 Anja Then-Kania Postapproval CMC Changes in the United States with a Focus on Biopharmaceuticals - Current Status and an Outlook in the Pharmaceutical Development ***
2011 Kristina Tripp Case Study: Impact of a new German law ("AMNOG") to restructure the pharmaceutical market on a Generic Company
2011 Dr. Alexander Vuia First revision of the "Guideline on the Investigation of bioequivalence": BCS-based Biowaiver - opportunities and limitations
2011 Dr. Bettina Walter-Lorenzen Improvement of the workflow, quality and effective management of product information texts using a new database
2011 Dr. Günter Waxenecker The "Risk Based Approach" - an important tool for managing all the duties in Drug Regulatory Affairs ***
2011 Katrin Wengenroth Regulatory Challenges Due to Globalisation of Drug Development and Manufacture Focusing on the Quality of Medicinal Products ***
2011 Dr. Christian Wrehlke Development of a database concept for tracking and maintaining regional/country specific Product Information (PI) and PI requirements
2011 Frauke Zeller, (geb. Tuchalski) Development of a new medicinal product containing a NCE intended for global marketing taking national regulations and requirements in the MENA region into consideration
2010 Sigrun Adrian Die Entwicklung unterschiedlicher Rechtsvorschriften und deren Überwachung im Bereich der Sicherheit von Arzneimitteln und Medizinprodukten in Deutschland (Pharmako- und Medizinproduktevigilanz)
2010 Stanislaus Awrutski Drug Regulatory Affairs and Marketing Authorisation in the Post-Soviet countries. Focus: Russia, the Ukraine and Belarus
2010 Dr. med. Maria Ida Behrens Chances for children with rare diseases under the Regulation EC 1901/2006
2010 Viktoria Behse Current experience with PIP approvals ***
2010 Dr. Anne Benzinger Regulatory requirements for preclinical development of bispecific antibodies ***
2010 Hanna Bölke Harmonisation of Product Information Texts of Generic Medicinal Products in EU – And its Impact on the Necessity of User Testing and Bridging
2010 Romuald Braun White Spots in Document Management in the Life Sciences Industry
2010 Dr. Dieter Brazel Regulatory Life Cycle Management of Plasma Protein Therapeutics ***
  • Total: 968